By Bill Whitford (DPS Group), Betsy Macht (Johnson & Johnson, retired), and Toni Manzano (Aizon) AI in Operations Bias in analysis or prediction is the disproportionate, improper weight or importance to an idea or thing. There are many sources of bias in analysis and modeling, and they can arise from the initial design of the … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team AI is a relatively mature field (officially born during the Dartmouth Conference in 1956) [1]. The current confluence of virtually unlimited data storage space and computational power has changed many aspects of algorithm design and implementation. For example, it … Read more
By William Whitford (DPS Group) Purpose: AI has applications throughout the value chain, and here we introduce an application in product development. AI in Modern Medicine Artificial Intelligence (AI) is one of the major techniques defining our modern era of medicine. The various machine learning algorithms employed in drug design include Supervised Learning, Unsupervised Learning, Semi-Supervised … Read more
By Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group), and AIO Team Healthcare Products Collaborative (formerly Xavier Health) is committed to improving the progression of healthcare by supporting teams of representatives of academia, solution suppliers, and pharmaceutical product sponsors to discover and publish on the newest trends and technologies. In this blog entry by … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team AI is a combination of statistics, math, algorithms and software able to establish links between the complexity of reality and the emergence of specific behaviors created by the intricate relationships of the studied units. The human body is maybe … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team In our last blog entry, we discussed the whats and whys around artificial intelligence (AI) transforming manufacturing. This entry sheds light upon some of the hows in anonymized accounts of real-life implementations. AI can present opportunities to improve production … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team Artificial Intelligence (AI)-supported real-time monitoring and advanced data techniques provide many benefits in modern manufacturing operations. These include maintaining materials inventory, troubleshooting production bottlenecks, maintaining instruments in operating order, avoiding product quality excursions, understanding scrap rates, meeting promised delivery … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), William Whitford (DPS Group) and AIO Team Having data of quality is the first step in the Artificial Intelligence (AI)/ Machine Learning (ML) journey to get reliable models and valuable AI/ML outputs. There are many issues regarding data quality that can affect the design of the … Read more
By Toni Manzano (Aizon), Mario Stassen (Stassen Pharmaconsult BV), and AIO Team The statistical methods and mathematical procedures used in the pharmaceutical industry are pieces of analysis that provide critical information for decision-making. Assuming mathematics are used as an instrument in manufacturing operations, it must be managed in the same way as equipment. Artificial Intelligence … Read more
The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.
Stay in the know about upcoming events and breaking news from the collaborative.
SubscribeHave questions about our events or how to get involved with one of our committees or workgroups?
Get in touch© 2024 AFDO/RAPS Healthcare Products Collaborative